A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease (Q41037243)
Jump to navigation
Jump to search
scientific article published on January 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease |
scientific article published on January 1998 |
Statements
1 reference
A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease (English)
1 reference
Lapchak PA
1 reference
1 January 1998
1 reference
1 reference
13 Suppl 1
1 reference